[1]

Park EK, Cho KR, Bo Seo K, et al. Additional Value of Diffusion-Weighted Imaging to Evaluate Prognostic Factors of Breast Cancer: Correlation with the Apparent Diffusion Coefficient[J/OL]. Iran J Radiol, 2016, 13(1): e33133[2019-03-07]. https://www.ncbi.nlm.nih.gov/pubmed/27127582. DOI: 10.5812/iranjradiol.33133.
[2]

杨义文, 胡春洪, 朱默, 等. MRI表观扩散系数联合动态增强TIC类型对肿块型浆细胞性乳腺炎及乳腺癌的鉴别诊断价值[J]. 磁共振成像, 2019, 10(7): 530−534. DOI: 10.12015/issn.1674−8034.2019.07.010.

Yang YW, Hu CH, Zhu M, et al. The differential diagnosis value of MRI apparent diffusion coefficient value combined with dynamic contrast enhanced MRI time-intensity curve type for mass plasma cell mastitis and breast cancer[J]. Chin J Magn Reson Imaging, 2019, 10(7): 530−534. DOI: 10.12015/issn.1674−8034.2019.07.010.
[3] Belli P, Costantini M, Bufi E, et al.  Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors[J]. Radiol Med, 2015, 120(3): 268-276.   doi: 10.1007/s11547-014-0442-8
[4] 许良中, 杨文涛.  免疫组织化学反应结果的判断标准[J]. 中国癌症杂志, 1996, 6(4): 229-231.   doi: 10.19401/j.cnki.1007-3639.1996.04.001
Xu LZ, Yang WT.  Criteria for the outcome of immunohistochemical reactions[J]. China Oncol, 1996, 6(4): 229-231.   doi: 10.19401/j.cnki.1007-3639.1996.04.001
[5] 刘静, 钟玲, 陈庆秋, 等.  乳腺癌发生过程中ER、PR、HER-2及WT1蛋白表达变化的研究[J]. 临床肿瘤学杂志, 2019, 24(8): 722-726.   doi: 10.3969/j.issn.1009-0460.2019.08.010
Liu J, Zhong L, Chen QQ, et al.  Changes of ER, PR, HER-2 and WT1 protein expression during the development of breast cancer[J]. Chin Clin Oncol, 2019, 24(8): 722-726.   doi: 10.3969/j.issn.1009-0460.2019.08.010
[6] Bae MS, Seo M, Kim KG, et al.  Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes[J]. Acta Radiol, 2015, 56(3): 269-275.   doi: 10.1177/0284185114524197
[7] María del RTS, Teresa SM, Petit A, et al.  Digital quantification of KI-67 in breast cancer[J]. Virchows Archiv, 2019, 474(2): 169-176.   doi: 10.1007/s00428-018-2481-3
[8] Alexey S, Paola C, Yun-Woo C, et al.  Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis[J]. Breast Cancer Res, 2018, 20(1): 58-62.   doi: 10.1186/s13058-018-0991-1
[9] Juanjuan L, Yue X, Qi W, et al.  Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program[J]. Oncotarget, 2017, 8(30): 49370-49379.   doi: 10.18632/oncotarget.17217
[10] 李芹, 牛庆亮, 杜汉旺, 等.  肿块型与非肿块型乳腺癌ADC值、Ki67指数的对比分析[J]. 中国临床医学影像杂志, 2018, 29(1): 11-13, 27.   doi: 10.3969/j.issn.1008-1062.2018.01.004
Li Q, Niu QL, Du HW, et al.  Comparative analysis of ADC value and Ki67 index in mass-like and non-mass-like breast cancer[J]. J China Clin Med Imaging, 2018, 29(1): 11-13, 27.   doi: 10.3969/j.issn.1008-1062.2018.01.004
[11] Aydin H, Guner B, Esen Bostanci I, et al.  Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?[J]. Br J Radiol, 2018, 91(1084): 20170705-.   doi: 10.1259/bjr.20170705
[12] Kamitani T, Matsuo Y, Yabuuchi H, et al.  Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer[J]. Magn Reson Med Sci, 2013, 12(3): 193-199.   doi: 10.2463/mrms.2012-0095
[13] Trihia H, Murray S, Price K, et al.  Ki-67 expression in breast carcinoma: Its association with grading systems, clinical parameters, and other prognostic factors-A surrogate marker?[J]. Cancer, 2003, 97(5): 1321-1331.   doi: 10.1002/cncr.11188
[14] Jeh SK, Kim SH, Kim HS, et al.  Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma[J]. J Magn Reson Imaging, 2011, 33(1): 102-109.   doi: 10.1002/jmri.22400
[15]

Choi SY, Chang YW, Park HJ, et al. Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer[J/OL]. Br J Radiol, 2012, 85(1016): e474-479[2019-03-07]. https://www.ncbi.nlm.nih.gov/pubmed/22128125. DOI: 10.1259/bjr/79381464.
[16] Youk JH, Son EJ, Chung J, et al.  Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes[J]. Eur Radiol, 2012, 22(8): 1724-1734.   doi: 10.1007/s00330-012-2425-2
[17] Uematsu T, Kasami M, Yuen S.  Triple-Negative Breast Cancer: Correlation Between MR Imaging and Pathologic Findings[J]. Radiology, 2009, 250(3): 638-647.   doi: 10.1148/radiol.2503081054
[18]

郜莹莹, 刘艳, 杨爱梅. 三阴性乳腺癌与HER-2过表达型乳腺癌MRI动态增强特征及ADC值分析[J]. 实用放射学杂志, 2014, 30(4): 606-609. DOI: 10.3969/j.issn.1002-1671.2014.04.016.

Gao YY, Liu Y, Yang AM. DCE-MRI features and ADC value analysis in triple-negative breast cancer and HER-2 overexpression subtype of breast cancer[J]. J Pract Radiol, 2014, 30(4): 606-609. DOI: 10.3969/j.issn.1002-1671.2014.04.016.